PIK3CA and APC mutations are synergistic in the development of intestinal cancers. - Wikidata - wikimedia - TriplyDB

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

http://www.wikidata.org/entity/Q37445892

about

Mouse models of intestinal cancer Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology Phospholipid ether analogs for the detection of colorectal tumors.Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.Algorithmic methods to infer the evolutionary trajectories in cancer progression.Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression.The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.A seven-gene signature predicts overall survival of patients with colorectal cancer.Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.Apc inactivation, but not obesity, synergizes with Pten deficiency to drive intestinal stem cell-derived tumorigenesis.A proteomic landscape of diffuse-type gastric cancer.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue

P2860

Q26785563-4E529B20-24CB-4394-868B-D0954C5C3797 Q27011884-2ABC238D-02B8-4217-AA0F-401526E8BF4D Q34294317-E0DEFFB8-54B2-43B5-9CE4-05240D566BA5 Q35919716-27454C47-1889-4023-A33D-996FD0D0648C Q36132776-0EB665A3-D11D-40D4-A16E-3AB77D8C75D1 Q37102361-59CC35A4-36C9-41AE-928E-EC577D3DD442 Q37139174-63BE0ED4-6291-4827-829C-34B2D7C8A025 Q37440936-71BE283B-D6D4-4AB0-B82C-4FA2565ADB41 Q37708839-ABE57DB8-C74F-46F7-8337-405D3C8E0EC7 Q39030149-38AAC449-A383-4172-AE67-F23430D66481 Q39752527-09FAC41F-7351-4CBE-9E0A-E0BEE233FD80 Q44943773-6E70CFE6-1A1F-475F-8220-B74E86A7362B Q47103045-8428B276-BDEC-4330-A45C-9D91AA9DCC36 Q47972738-0B8BD01B-80B6-4771-8733-0ED2020CCCB5 Q51832160-6D1A4216-5118-43CF-A5EC-5D747647CC12 Q52727768-5A58C048-FE66-4FF5-A629-D00FEB13685D Q55411157-62994F31-4195-42C8-9BEE-409602C92E16 Q57168934-9A58DDB9-841D-47E7-BE97-62F989FD8F8F

P2860

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

http://www.wikidata.org/entity/Q37445892

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@en

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@nl

type

label

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@en

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@nl

prefLabel

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@en

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@nl

P1433

Q37445892-A76E4170-43E2-44AE-B2C6-0FDCF09513E4

P1476

Q37445892-094FA864-755E-4CDA-AFD6-6FCEFB58F5F4

P2093

Q37445892-01A722DA-FD2D-4802-A2E8-FC832B2266D5

Q37445892-196853BE-50F9-4755-A8A8-8EB219931688

Q37445892-5AFD10D3-4039-4FB3-B32A-44096248355A

Q37445892-60C64FA1-CF55-4856-90FA-E02606237314

Q37445892-61D495AF-7409-4D2F-94DF-74927FE02F95

Q37445892-68B5F48A-E661-480A-9EC3-0B614EB72374

Q37445892-9A4EB524-6DB2-4B8F-992B-398770084717

Q37445892-A903EEC5-62B3-4A81-BC22-095E01F097D2

Q37445892-CD7E9FA2-8A1E-4FC5-9FC3-6FBB3FBEA13B

Q37445892-DEEB1232-B7C1-4F6B-A81B-E76E55A7EE63

P2860

Q37445892-03056F22-FEC1-4629-9A76-6D8D0DB4DEAA

Q37445892-09453176-F2A5-4F5A-8A72-28829A57B233

Q37445892-154A5C36-8248-45B8-9240-425F17D8E6DF

Q37445892-177A461F-5F17-4AB2-880B-0B21B13CE656

Q37445892-1C7334A4-C35D-4E02-B640-F2957D7815BC

Q37445892-1EE8AAFF-9522-4675-92F3-0BDBC35C0160

Q37445892-261A91EA-AF70-44A4-A2F3-0618C721EB46

Q37445892-2AC68277-6E3B-4853-B718-0B127AE01689

Q37445892-334133F5-50C5-47F6-B9D9-AC1E91E0D402

Q37445892-42CBB0AC-FFCE-4AA2-A1E0-02AA1955EBD9

P2888

Q37445892-99A89C16-1C64-48B1-B605-9288111EE439

P304

Q37445892-ED97620E-B18F-4395-AE26-742834A4D814

P31

Q37445892-A1337FF7-0FCA-4526-8A79-50A69ED2649A

P356

Q37445892-31DAD0BC-32CA-4C4D-9D5B-30358AE490CC

P407

Q37445892-BB8BF1A5-8DA5-4D52-9647-7EE1E3D46FB9

P433

Q37445892-8DA1C998-D2FF-4DE6-8692-378698821594

P478

Q37445892-FDA5DCC3-62BD-41D4-8978-55091EC60EE8

P577

Q37445892-803DCB35-21E5-4E07-A0B9-DBE9A35089BE

P5875

Q37445892-AA6C723F-9A9C-4F63-B732-205385E12AFE

P698

Q37445892-78D28E91-2747-4427-8C8A-77E980CAAF58

P932

Q37445892-45A4C145-2F0F-4890-92D5-3FC098E6F7A3

P356

P1433

P1476

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

@en

P2093

A A Leystra

http://www.w3.org/2001/XMLSchema#string

C Sievers

http://www.w3.org/2001/XMLSchema#string

D A Deming

http://www.w3.org/2001/XMLSchema#string

D Albrecht

http://www.w3.org/2001/XMLSchema#string

D Miller

http://www.w3.org/2001/XMLSchema#string

J Bacher

http://www.w3.org/2001/XMLSchema#string

J Weichert

http://www.w3.org/2001/XMLSchema#string

L Clipson

http://www.w3.org/2001/XMLSchema#string

L Nettekoven

http://www.w3.org/2001/XMLSchema#string

M K Washington

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular origins of cancer: Molecular basis of colorectal cancer

GSK-3: tricks of the trade for a multi-tasking kinase

Comprehensive molecular characterization of human colon and rectal cancer

Wnt/β-catenin signaling and disease

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

High frequency of mutations of the PIK3CA gene in human cancers

Biology of the adenomatous polyposis coli tumor suppressor

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene

P2888

P304

2245-2254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2013.167

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236939796

http://www.w3.org/2001/XMLSchema#string

P698

23708654

http://www.w3.org/2001/XMLSchema#string

P932

3883937

http://www.w3.org/2001/XMLSchema#string